Nanomodulators That Target Alzheimer’s Disease: A Review
Source abstract
Abstract
The vastness and multidimensional adversity of Alzheimer’s disease (AD) impede the outgrowth of its therapeutic research. Needless to say, the application of nanoscience has amplified the progress of prophylaxis and therapeutics development for AD. In this Review, we will elaborate on the advancement of a nanoparticle-based alternative therapeutic targeting AD in terms of design, approach, mechanism of action, and limitations associated with their clinical availability. So far, the blood–brain barrier (BBB) is one of the major hurdles for the clinical application of drugs for any neurodegenerative disease. Here, we will focus on the current state-of-the-art of nanoparticle-based therapeutics for crossing the BBB.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Alzheimer's disease research and treatments · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Life Sciences, Kristu Jayanti College (Autonomous), Bangalore 560077, India
School of Bioscience, Indian Institute of Technology Kharagpur, Kharagpur 721302, India
Funding
Science and Engineering Research Board
References (100+)
Show source-provided references
1. Alzheimer’s Association. · Alzheimers Dement. · 2021 · 17 · 32710.1002/alz.12328 ↗
2. 10.1002/alz.1301610.1002/alz.13016 ↗
3. 10.1021/acschemneuro.7b0018810.1021/acschemneuro.7b00188 ↗
4. 10.1038/nature1932310.1038/nature19323 ↗
5. 10.1007/s40265-021-01569-z10.1007/s40265-021-01569-z ↗
6. 10.1056/NEJMoa221294810.1056/NEJMoa2212948 ↗
7. 10.1016/S1474-4422(13)70044-910.1016/S1474-4422(13)70044-9 ↗
8. 10.1021/acs.chemrev.0c0112210.1021/acs.chemrev.0c01122 ↗
9. 10.1038/s41593-018-0235-910.1038/s41593-018-0235-9 ↗
10. 10.1146/annurev.ne.17.030194.00242110.1146/annurev.ne.17.030194.002421 ↗
11. 10.2174/092986604340717410.2174/0929866043407174 ↗
12. 10.1017/S003358350600442210.1017/S0033583506004422 ↗
13. 10.1126/science.107299410.1126/science.1072994 ↗
14. 10.1016/j.npep.2015.06.00810.1016/j.npep.2015.06.008 ↗
15. 10.1073/pnas.83.13.491310.1073/pnas.83.13.4913 ↗
16. 10.1016/j.semcdb.2003.12.01510.1016/j.semcdb.2003.12.015 ↗
17. 10.1073/pnas.86.8.285310.1073/pnas.86.8.2853 ↗
18. 10.1016/S0955-0674(05)80038-910.1016/S0955-0674(05)80038-9 ↗
19. 10.1016/0197-4580(95)00025-A10.1016/0197-4580(95)00025-A ↗
20. 10.1111/j.1749-6632.1993.tb23054.x10.1111/j.1749-6632.1993.tb23054.x ↗
21. 10.1016/j.bbr.2009.12.04410.1016/j.bbr.2009.12.044 ↗
22. 10.1124/jpet.102.04161610.1124/jpet.102.041616 ↗
23. 10.1016/S0962-8924(98)01363-410.1016/S0962-8924(98)01363-4 ↗
24. 10.1186/1750-1326-1-510.1186/1750-1326-1-5 ↗
25. 10.1016/0166-2236(93)90078-Z10.1016/0166-2236(93)90078-Z ↗
26. 10.1021/cr300099410.1021/cr3000994 ↗
27. 10.1007/978-3-7091-6467-9_1510.1007/978-3-7091-6467-9_15 ↗
28. 10.1073/pnas.91.12.556210.1073/pnas.91.12.5562 ↗
29. 10.2174/15672051079361159210.2174/156720510793611592 ↗
30. 10.1073/pnas.060321410310.1073/pnas.0603214103 ↗
31. 10.1016/j.jalz.2018.02.01810.1016/j.jalz.2018.02.018 ↗
32. 10.1186/s40035-022-00296-z10.1186/s40035-022-00296-z ↗
33. 10.1007/s00259-015-3228-x10.1007/s00259-015-3228-x ↗
34. 10.1007/s00259-021-05401-410.1007/s00259-021-05401-4 ↗
35. 10.1038/s12276-019-0250-210.1038/s12276-019-0250-2 ↗
36. 10.1016/j.jalz.2016.09.01410.1016/j.jalz.2016.09.014 ↗
37. 10.3233/JAD-14075610.3233/JAD-140756 ↗
38. 10.1016/j.bbrc.2016.08.06710.1016/j.bbrc.2016.08.067 ↗
39. 10.1016/j.dadm.2016.12.01410.1016/j.dadm.2016.12.014 ↗
40. 10.1016/j.tips.2015.03.00210.1016/j.tips.2015.03.002 ↗
41. 10.1038/s12276-020-0418-910.1038/s12276-020-0418-9 ↗
42. 10.1038/s41380-021-01249-010.1038/s41380-021-01249-0 ↗
43. 10.1186/s40035-017-0077-510.1186/s40035-017-0077-5 ↗
44. 10.1159/00048500810.1159/000485008 ↗
45. Epperly T. · Am. Fam. Physician · 2017 · 95 · 771
46. 10.3390/biomedicines704009710.3390/biomedicines7040097 ↗
47. 10.1038/s41593-018-0250-x10.1038/s41593-018-0250-x ↗
48. 10.1001/jama.2021.385410.1001/jama.2021.3854 ↗
49. 10.1038/s41582-021-00557-x10.1038/s41582-021-00557-x ↗
50. 10.3390/molecules2524578910.3390/molecules25245789 ↗
51. 10.1038/s41598-022-21820-110.1038/s41598-022-21820-1 ↗
52. 10.1186/s40824-019-0166-x10.1186/s40824-019-0166-x ↗
53. 10.1016/j.ejpb.2021.04.02510.1016/j.ejpb.2021.04.025 ↗
54. NIA-Funded Active Alzheimer’s and Related Dementias Clinical Trials and Studies, 2023; https://www.nia.nih.gov/research/ongoing-AD-trials#section2.
55. https://clinicaltrials.gov (aceessed on 14 December 2023).
56. 10.1016/j.arr.2021.10133910.1016/j.arr.2021.101339 ↗
57. 10.1038/s41582-021-00545-110.1038/s41582-021-00545-1 ↗
58. 10.1111/j.1471-4159.2010.07081.x10.1111/j.1471-4159.2010.07081.x ↗
59. 10.3389/fneur.2020.0061410.3389/fneur.2020.00614 ↗
60. 10.1016/j.addr.2022.11439710.1016/j.addr.2022.114397 ↗
61. 10.2174/156720501666619030111112010.2174/1567205016666190301111120 ↗
62. Product Pipeline, 2016–2023; https://alzamend.com/pipeline.
63. 10.1016/j.jchemneu.2020.10179510.1016/j.jchemneu.2020.101795 ↗
64. 10.1021/acschemneuro.1c0003510.1021/acschemneuro.1c00035 ↗
65. 10.1016/j.biomaterials.2020.12016510.1016/j.biomaterials.2020.120165 ↗
66. 10.1039/D0TB01863E10.1039/D0TB01863E ↗
67. 10.1021/acsami.7b0651010.1021/acsami.7b06510 ↗
68. 10.1021/acsami.7b0188610.1021/acsami.7b01886 ↗
69. 10.1021/acsami.6b0685310.1021/acsami.6b06853 ↗
70. 10.1002/chem.20140007910.1002/chem.201400079 ↗
71. 10.1021/jp505613g10.1021/jp505613g ↗
72. 10.1007/s10876-019-01735-010.1007/s10876-019-01735-0 ↗
73. 10.1016/j.actbio.2016.09.01010.1016/j.actbio.2016.09.010 ↗
74. 10.1002/ange.20200792410.1002/ange.202007924 ↗
75. 10.1098/rsfs.2016.016010.1098/rsfs.2016.0160 ↗
76. 10.1038/s41467-023-41489-y10.1038/s41467-023-41489-y ↗
77. 10.1021/acsbiomaterials.1c0060510.1021/acsbiomaterials.1c00605 ↗
78. Wang J. · 201310.1002/9783527651450 ↗
79. 10.1021/acsami.0c0234210.1021/acsami.0c02342 ↗
80. 10.1021/acsnano.0c0607810.1021/acsnano.0c06078 ↗
81. 10.1021/acsami.1c0306610.1021/acsami.1c03066 ↗
82. 10.1002/adma.20110486410.1002/adma.201104864 ↗
83. 10.1007/s12274-015-0821-z10.1007/s12274-015-0821-z ↗
84. 10.1039/C9NR01845J10.1039/C9NR01845J ↗
85. 10.1021/acsami.6b0508910.1021/acsami.6b05089 ↗
86. 10.7150/thno.3064910.7150/thno.30649 ↗
87. 10.1021/acsami.9b2221410.1021/acsami.9b22214 ↗
88. 10.1021/acsnano.0c0273310.1021/acsnano.0c02733 ↗
89. 10.1007/s12274-016-1000-610.1007/s12274-016-1000-6 ↗
90. 10.1021/jacs.0c0839510.1021/jacs.0c08395 ↗
91. 10.1016/j.biomaterials.2019.11975210.1016/j.biomaterials.2019.119752 ↗
92. 10.1016/j.biomaterials.2020.12016010.1016/j.biomaterials.2020.120160 ↗
93. 10.1021/acs.jpcc.6b1230710.1021/acs.jpcc.6b12307 ↗
94. 10.1039/C7NR00699C10.1039/C7NR00699C ↗
95. 10.3389/fnins.2018.0002510.3389/fnins.2018.00025 ↗
96. 10.1083/jcb.103.6.273910.1083/jcb.103.6.2739 ↗
97. Imahori K. · J. Biochem. (Tokyo) · 1997 · 121 · 179
98. 10.1007/s00702-004-0221-010.1007/s00702-004-0221-0 ↗
99. 10.1073/pnas.83.13.491310.1073/pnas.83.13.4913 ↗
100. 10.1016/S0021-9258(17)38495-810.1016/S0021-9258(17)38495-8 ↗